Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-30T15:51:23.045Z Has data issue: false hasContentIssue false

Flupenthixol Decanoate in Schizophrenia

Published online by Cambridge University Press:  29 January 2018

H. Trueman
Affiliation:
Glenside Day Hospital, Bristol BS16 1DD
M. Valentine
Affiliation:
Glenside Day Hospital, Bristol BS16 1DD

Extract

The anti-psychotic properties of flupenthixol have been described by Gottfries (1971) and Gross and Kaltenback (1965), and its antidepressant action by Reiter (1969), Merskey (1971), and Hall and Coleman (1973). It is available in the form of its decanoate in oil (‘Depixol’) as a depot injection.

Type
Abstract
Copyright
Copyright © Royal College of Psychiatrists, 1974 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gottfries, C. G. (1971). ‘Flupenthixol and trifluperazine: a double-blind investigation in the treatment of schizophrenia.British Journal of Psychiatry, 119, 547–8.Google Scholar
Gross, H., and Kaltenback, E. (1965). ‘Flupenthixol, a new neuroleptic agent of the thiaxanthene group.Acta Psychiatrica Scandinavka, 41, 1, 4356.Google Scholar
Hall, P., and Coleman, J. (1973). ‘Flupenthixol in the treatment of depressive states.British Journal of Psychiatry, 122, 120.Google Scholar
Merskey, J. (1971). ‘Flupenthixol (Fluanxol).British Journal of Psychiatry, 119, 230.Google Scholar
Reiter, P. J. (1969). ‘On flupenthixol, an antidepressant of a new chemical group.British Journal of Psychiatry, 115, 13991402.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.